Sam Altman: AI to cure most diseases by 2035
OpenAI CEO Sam Altman has forecasted that artificial superintelligence will cure the majority of human diseases by 2035, adding an extra 10 healthy years to average lifespans. In a CNN interview, Altman highlighted AI's transformative potential in medicine, particularly through his portfolio company Retro Biosciences, which focuses on longevity research.
Altman emphasized that superintelligence—a form of AI vastly exceeding human cognitive abilities—will dramatically accelerate medical breakthroughs. He pointed to AI's capacity to enable personalized treatments and revolutionize drug discovery, potentially tackling complex diseases that have long eluded conventional science. His investment in Retro Biosciences underscores a broader bet on aging as a treatable condition, aiming to extend human healthspan rather than just lifespan.
The forecast underscores AI's disruptive potential in biotechnology, though the 2035 timeline is ambitious. Significant hurdles remain, including ethical considerations around access and the equitable distribution of advanced therapies. Altman's vision, while bold, aligns with a growing consensus among tech leaders that AI could unlock the next frontier in healthcare.
